New nasal spray for migraine put to the test in Real-World study
NCT ID NCT07100496
First seen Apr 03, 2026 · Last updated May 13, 2026 · Updated 7 times
Summary
This study tests a nasal spray device called MIG-SPRAY in 45 adults with migraine to see how well it is tolerated. Participants are randomly assigned to use the device or not, and they report any side effects and migraine episodes daily. The goal is to compare side effects, migraine frequency, and disability between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Clermont-ferrand
Clermont-Ferrand, 63000, France
Conditions
Explore the condition pages connected to this study.